Cipla signs a licensing agreement with Belgium based firm, Multi G for the distribution of their COVID-19. Rapid Antibody test kit, across most Emerging markets and Europe.
DLF saw sales of Rs.750 crore in Q3 & Q4FY21 and expected to clock sales of Rs.1,000 crore beyond M2FY21, whole-time director Ashok Tyagi.
FII bought close to Rs.5,000 crore of shares. F & O market, there has been unwinding of shorts 5,100 and addition of 5, longs.
Bank Nifty wants to go to its all-time high which is visible, it's gone up 22% already this month with 10% from its peak now.
The big Conundrum right now seems to be that money is chasing large caps to chase. Nifty is its peak valuation and big caps have been underperforming.
We could be at the cusp of a big/bull market rally. Reliance remains the only weak link in the Stock Market right now.
Nasdaq relatively outperforms the market, its losses capped by a surging Tesla (+8%)
A combination of strong domestic economic data, corporate earnings upgrades, and favorable vaccine/ COVID trends are making us more optimistic about the cyclical recovery in India. We raise further weight on banks, materials and L&T says, Jefferies.
They reduce the weight of staples IT, insurance, 2 -wheelers, and Bharat Forge. He adds the PSU index is also doing well on Rate, SBI & CONCOR are their top PSU kick, which is gaining currencies.
India reports 38,617 cases in the last 24 hours; 32% higher than the previous rise. Single-day testing higher from yesterday, but still below 10 lakh. Active cases fall by 6,596 while total cases rise by 38,617 in the last 24 hours in India.
